Profile
James Schaub is currently the Chief Operating Officer & Executive Vice President at RVL Pharmaceuticals Plc since 2016.
Prior to this, he worked as the Vice President-Mergers & Acquisitions at Fougera Pharmaceuticals, Inc. from 2011 to 2012.
He also served as the Chief Operating Officer at Trigen Laboratories LLC.
Mr. Schaub completed his undergraduate degree from Middlebury College and earned an MBA from Rutgers Business School.
James Schaub active positions
| Companies | Position | Start |
|---|---|---|
| RVL PHARMACEUTICALS PLC | Chief Operating Officer | 01/01/2016 |
Former positions of James Schaub
| Companies | Position | End |
|---|---|---|
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures specialty pharmaceuticals in dermatology | Corporate Officer/Principal | 01/09/2012 |
Trigen Laboratories LLC
Trigen Laboratories LLC Drugstore ChainsRetail Trade Operates as a generic pharmaceutical company | Chief Operating Officer | - |
Training of James Schaub
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures specialty pharmaceuticals in dermatology | Health Technology |
Trigen Laboratories LLC
Trigen Laboratories LLC Drugstore ChainsRetail Trade Operates as a generic pharmaceutical company | Retail Trade |
Rutgers Business School
Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RVL Pharmaceuticals Plc
RVL Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- James Schaub
















